The COVID-19 pandemic continues to evolve in 2022 as well and so are its adverse impacts on businesses and different industries. Especially, the pharmaceutical industry is facing major upsetting and challenges as clinical trials is not going any better during these tough times.
With no further assurance for how long will this pandemic be continued, the pharma industry must utilize this time and set alternatives to come up with outstanding strategies to ensure clinical trials are performed smoothly and hassle-free.
This will help them to stay prepared so they can handle similar uncertainties in the future with ease.
The clinical trials management system has already encountered multifaceted issues. Here’s the list of some new challenges they have witnessed during the lock-downs –
Multispecialty hospitals and healthcare IT services providers must dedicate large parts of their facilities and services to Covid-19 patients’. Such hospitals that are also handling the Covid patients are putting participating patients of clinical trials at major risk of acquiring the infection.
As Clinical trials are being the central mechanism for effective evaluation to analyze how IT Services for Healthcare are performing and how treatments and patients’ management are going, they can’t be ignored at any cost. Turning to technology and digital innovation could be the perfect solution to be saved from this inevitable problem!
White the Covid-19 outbreak doesn’t seem to end soon, ‘Digital clinical trials’ should be on track as soon as possible to become a reality.
Organizations have already started preparing for the post-covid world and analyzing how are they going to deal with the whole disrupted clinical trials management system.
Here we have enlisted a few of the best ways through which organizations can start to adapt their clinical processes for a post-Covid world. Let’s have a look!
Setting up standard processes to support transparency and privacy of patients’ personal data would surely be the biggest challenge. So, the companies that comply with the standards regulations as in the General Data Protection Regulation (GDPR) in the EU and the California Consumer Privacy Act (CCPA) in the USA have already started doing so.
However, to get desired outcomes they need to reassure that the patients’ privacy got no leaks.
Start analyzing the data gaps in current repositories like an Electronic Health Record (EHR) and the real-world data collected from mobile apps or smart wearable devices.
AI could be a great technology to do so as it would be a great way to bring innovative solutions forward.
Institutes can use smart clinical trials management software to bring patients and institutes together virtually. This way the possibilities of spreading infection would be minimal and we would be able to replace 25-40% of standard clinical trial visits through decentralized clinical visits.
As Covid-19 has greatly impacted the clinical trials and still continues to do, we will get a large volume of new data.
This would be an opportunity for us to come together and establish new practices that will streamline the clinical trials management systems in the post-covid world and equip us with the agility to connect therapies to patients effectively.
All your ideas are protected by NDA
Detailed time and cost estimation
Helping to shape your idea and scope